Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.32 USD | +2.25% | +0.98% | +33.00% |
04/06 | Oppenheimer Raises Price Target on Crinetics Pharmaceuticals to $74 From $55, Maintains Outperform Rating | MT |
03/06 | Transcript : Crinetics Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.00% | 373.24Cr | |
+46.19% | 5.57TCr | |
-6.14% | 3.96TCr | |
+39.41% | 3.99TCr | |
-6.65% | 2.82TCr | |
+12.33% | 2.63TCr | |
-21.78% | 1.89TCr | |
-0.35% | 1.21TCr | |
+24.18% | 1.21TCr | |
+28.38% | 1.22TCr |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Transcript : Crinetics Pharmaceuticals, Inc. - Special Call